【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Cardiovascular Inflammation 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Cardiovascular Inflammation 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Cardiovascular Inflammation Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Teijin Pharma Limited 35
Clinical Trial Overview of Teijin Pharma Limited 35
Genentech, Inc. 36
Clinical Trial Overview of Genentech, Inc. 36
AstraZeneca PLC 37
Clinical Trial Overview of AstraZeneca PLC 37
Sanofi 38
Clinical Trial Overview of Sanofi 38
TNO Pharma 39
Clinical Trial Overview of TNO Pharma 39
Innovaderm Research Inc. 40
Clinical Trial Overview of Innovaderm Research Inc. 40
RNL BIO Co., Ltd. 41
Clinical Trial Overview of RNL BIO Co., Ltd. 41
Troikaa Pharmaceuticals Ltd. 42
Clinical Trial Overview of Troikaa Pharmaceuticals Ltd. 42
Janssen Biotech, Inc. 43
Clinical Trial Overview of Janssen Biotech, Inc. 43
Anthera Pharmaceuticals‚ Inc. 44
Clinical Trial Overview of Anthera Pharmaceuticals‚ Inc. 44
Cumberland Pharmaceuticals, Inc. 45
Clinical Trial Overview of Cumberland Pharmaceuticals, Inc. 45
Pluristem Therapeutics Inc. 46
Clinical Trial Overview of Pluristem Therapeutics Inc. 46
UMC Utrecht Holding BV 47
Clinical Trial Overview of UMC Utrecht Holding BV 47
Immunomedics, Inc. 48
Clinical Trial Overview of Immunomedics, Inc. 48
Robert Bosch GmbH 49
Clinical Trial Overview of Robert Bosch GmbH 49
Human Genome Sciences, Inc. 50
Clinical Trial Overview of Human Genome Sciences, Inc. 50
Clinical Trial Overview of Top Institutes / Government 51
The National Institute of Allergy and Infectious Diseases 51
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 51
Assistance Publique – Hopitaux de Paris 52
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 52
University of Pennsylvania 53
Clinical Trial Overview of University of Pennsylvania 53
Cambridge University Hospitals NHS Foundation Trust 54
Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 54
National Heart, Lung, and Blood Institute 55
Clinical Trial Overview of National Heart, Lung, and Blood Institute 55
University of Oxford 56
Clinical Trial Overview of University of Oxford 56
Ministry of Health, Labour and Welfare, Japan 57
Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan 57
Azienda Sanitaria Locale Carbonia 58
Clinical Trial Overview of Azienda Sanitaria Locale Carbonia 58
Johns Hopkins University 59
Clinical Trial Overview of Johns Hopkins University 59
Duke University 60
Clinical Trial Overview of Duke University 60
National Eye Institute 61
Clinical Trial Overview of National Eye Institute 61
Leiden University Medical Center 62
Clinical Trial Overview of Leiden University Medical Center 62
National Taiwan University Hospital 63
Clinical Trial Overview of National Taiwan University Hospital 63
University Hospital, Toulouse 64
Clinical Trial Overview of University Hospital, Toulouse 64
Northwestern University 65
Clinical Trial Overview of Northwestern University 65
University of Sao Paulo 66
Clinical Trial Overview of University of Sao Paulo 66
Mayo Clinic 67
Clinical Trial Overview of Mayo Clinic 67
University Medical Center Groningen 68
Clinical Trial Overview of University Medical Center Groningen 68
University Hospitals Birmingham NHS Foundation Trust 69
Clinical Trial Overview of University Hospitals Birmingham NHS Foundation Trust 69
Griffith University 70
Clinical Trial Overview of Griffith University 70
Five Key Clinical Profiles 71
Appendix 153
Abbreviations 153
Definitions 153
Research Methodology 154
Secondary Research 154
About GlobalData 155
Contact Us 155
Disclaimer 155
Source 155
【レポート販売概要】
■ タイトル：Cardiovascular Inflammation：グローバル臨床試験レビューH2, 2013■ 英文：Cardiovascular Inflammation Global Clinical Trials Review, H2, 2013
■ 発行日：2013年8月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161729
■ 調査対象地域：グローバル
- 過眠症（Hypersomnia）：グローバル臨床試験動向（2014年上半期）Hypersomnia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Hypersomnia Global Clinical Trials Review, H1, 2014" provides data on the Hypersomnia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypersomnia. It includes an overview of the trial numbers and their recruitment status as per the site of …
- UAEの防衛市場動向Summary The Future of the UAE Defense Industry - Market Attractiveness, Competitive Landscape and Forecasts to 2019 published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast UAE defense industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies and key news. Key Findin …
- WiMAX Service Providers by Operator 2010WiMAX service providers have a rich environment to create real business, not only providing services to traditional customers, but also to developing a solid ecosystem with other technology developers which are seeking for enhancing their WiMAX-based developed products. This developed ecosystem facilitates certain advantages for all ecosystem partners and such advantages are reflected to customers …
- 世界のジェネリック医薬品（後発医薬品）市場動向（2014-2018）TechNavio's analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is also witnessing an increase in mergers and acquistions. However, intense competition among vendors could squeeze profit margins, increase pricing pressu …
- Samra Electric Power Co.：発電所及び企業SWTO分析2015Samra Electric Power Co. - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarize …
- レトルト用包装材料の世界市場：ポーチ、トレイ、カートンThe global retort packaging market is estimated to grow at a CAGR of 6.7% from 2015 to 2020. The growth of this market is propelled by an increase in the flexible packaging demand with convenience features. Retort packaging also plays an important role in meat, poultry, and beef packaging. With the emergence of new technologies, manufacturers are looking for advanced techniques to make retort pack …
- プレミアムA2P及びP2Aメッセージングの世界市場予測（～2021年）MarketsandMarkets forecasts the premium A2P and P2A messaging market size to grow from USD 55.49 Billion in 2016 to USD 71.60 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 5.23% from 2016 to 2021. Increasing mobile subscriber base, indispensable requirement to have ubiquitous and direct personal communication channel for enterprises to interact with their customers, rising use of mob …
- 商用車用エアディフレクターの世界市場ABSTRACTAbout Commercial Vehicle Air Deflector Commercial vehicle air deflectors are high-density plastic products used for preventing or reducing air drag and raising the aerodynamic qualities of the vehicle. Technavio’s analysts forecast the global commercial vehicle air deflector market to grow at a CAGR of 5% during the period 2017-2021. [Covered in this report] The report covers the present s …
- 世界の微生物資材市場：種類別（農業微生物資材、サイレージ微生物資材）、微生物別（細菌、真菌）、作物種類別（油料種子＆豆類、シリアル＆穀物、果物＆野菜、飼料）、地域別“The inoculants market is projected to grow at a CAGR of 6.9%, in terms of value.” The inoculants market is estimated to reach USD 808 million in 2019 and is projected to account for USD 1,207 million by 2025, recording a CAGR of 6.9% during the forecast period. In South America, countries such as Brazil and Argentina are projected to offer high growth prospects in the coming years, as they are ra …
- 世界における排ガス中の水銀制御用活性炭市場The report on activated carbon for mercury control in flue gas captures the global market size by volume and value. The global activated carbon for mercury control in flue gas is growing at a rapid pace in North America and Asia-Pacific. The demand of activated carbon for mercury control in flue gas is driven by the following factors: • Strict norms and regulations imposed by EPA and other regulat …
- 前臨床用画像システムの世界市場：マイクロMRI、マイクロPET、マイクロCT、PAT、SPECT、マルチモダリティー、光学イメージング、超音波装置About Pre-clinical Imaging Pre-clinical Imaging is in vivo imaging of small animals, which had been progressively deployed in drug development process. It helps in the visualizing and monitoring of animals for research with respect to tissue, organ, cell (at molecular level), and physiological and environmental changes. One of the main application areas of pre-clinical imaging is early detection o …
- 世界及び米国の金産業動向：Focusing on Gold and the US Gold IndustryGold is a highly sought-after precious metal which, for many centuries, has been used as money, a store of value and in jewelry. The metal occurs as nuggets or grains in rocks, underground "veins" and in alluvial deposits. Gold forms the basis for a monetary standard used by the International Monetary Fund (IMF) and the Bank for International Settlements (BIS). Modern industrial uses include denti …
- 世界の企業コンテンツ管理市場動向（2012-2016）TechNavio's analysts forecast the Global Enterprise Content Management market to grow at a CAGR of 12.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for regulatory compliance. The Global Enterprise Content Management market has also been witnessing an increased adoption of ECM in small and medium-sized enterprises (SMEs). However, existen …
- Ultra Petroleum Corp.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Ultra Petroleum Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Ultra Petroleum Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- 産業用クラッチ及びブレーキの世界市場2017-2021About Industrial Clutches and Brakes Clutches and brakes are widely used in industrial applications for transmitting mechanical power between the driving shaft and driven shaft. An industry chooses clutches, brakes, or a combination of these two based on application. Technavio’s analysts forecast the global industrial clutches and brakes market to grow at a CAGR of 1.65% during the period 2017-202 …
